TY - JOUR AU - Yoon, J. H. AU - Yhim, H. Y. AU - Kwak, J. Y. AU - Ahn, J. S. AU - Yang, D. H. AU - Lee, J. J. AU - Kim, S. J. AU - Kim, J. S. AU - Park, S. J. AU - Choi, C. W. PY - 2016 DA - 2016// TI - Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdw123 DO - 10.1093/annonc/mdw123 ID - Yoon2016 ER - TY - JOUR AU - Nishiwaki, S. AU - Imai, K. AU - Mizuta, S. AU - Kanamori, H. AU - Ohashi, K. AU - Fukuda, T. AU - Onishi, Y. AU - Takahashi, S. AU - Uchida, N. AU - Eto, T. PY - 2016 DA - 2016// TI - Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: a study from the adult ALL WG of the JSHCT JO - Bone Marrow Transplant VL - 51 UR - https://doi.org/10.1038/bmt.2015.217 DO - 10.1038/bmt.2015.217 ID - Nishiwaki2016 ER - TY - JOUR AU - Short, N. J. AU - Kantarjian, H. M. AU - Sasaki, K. AU - Ravandi, F. AU - Ko, H. AU - Cameron Yin, C. AU - Garcia-Manero, G. AU - Cortes, J. E. AU - Garris, R. AU - O'Brien, S. M. PY - 2017 DA - 2017// TI - Poor outcomes associated with +der (22) t (9,22) and −9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor JO - Am J Hematol VL - 92 UR - https://doi.org/10.1002/ajh.24625 DO - 10.1002/ajh.24625 ID - Short2017 ER - TY - JOUR AU - Fielding, A. K. PY - 2019 DA - 2019// TI - Curing Ph+ ALL: assessing the relative contributions of chemotherapy, TKIs, and allogeneic stem cell transplant JO - Hematology Am Soc Hematol Educ Program VL - 2019 UR - https://doi.org/10.1182/hematology.2019000010 DO - 10.1182/hematology.2019000010 ID - Fielding2019 ER - TY - JOUR AU - Yan, L. AU - Zhang, H. -. T. AU - Goncalves, J. AU - Xiao, Y. AU - Wang, M. AU - Guo, Y. AU - Sun, C. AU - Tang, X. AU - Jing, L. AU - Zhang, M. PY - 2020 DA - 2020// TI - An interpretable mortality prediction model for COVID-19 patients JO - Nature Machine Intelligence VL - 2 UR - https://doi.org/10.1038/s42256-020-0180-7 DO - 10.1038/s42256-020-0180-7 ID - Yan2020 ER - TY - JOUR AU - Nishiwaki, S. AU - Kim, J. AU - Ito, M. AU - Maeda, M. AU - Okuno, Y. AU - Koyama, D. AU - Ozawa, Y. AU - Gunji, M. AU - Osaki, M. AU - Kitamura, K. PY - 2020 DA - 2020// TI - Multi-lineage BCR-ABL expression in Philadelphia chromosome-positive acute lymphoblastic leukemia is associated with improved prognosis but no specific molecular features JO - Front Oncol VL - 10 UR - https://doi.org/10.3389/fonc.2020.586567 DO - 10.3389/fonc.2020.586567 ID - Nishiwaki2020 ER - TY - STD TI - Chen T, Guestrin C: XGBoost: A Scalable Tree Boosting System. arXiv:160302754v3 [csLG] 10 Jun 2016 2016. ID - ref7 ER - TY - JOUR AU - Ravandi, F. AU - Jorgensen, J. L. AU - Thomas, D. A. AU - O'Brien, S. AU - Garris, R. AU - Faderl, S. AU - Huang, X. AU - Wen, S. AU - Burger, J. A. AU - Ferrajoli, A. PY - 2013 DA - 2013// TI - Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy JO - Blood VL - 122 UR - https://doi.org/10.1182/blood-2012-11-466482 DO - 10.1182/blood-2012-11-466482 ID - Ravandi2013 ER - TY - JOUR AU - Litzow, M. R. PY - 2016 DA - 2016// TI - Should anyone with Philadelphia chromosome-positive ALL who is negative for minimal residual disease receive a hematopoietic stem cell transplant in first remission? JO - Best Pract Res Clin Haematol VL - 29 UR - https://doi.org/10.1016/j.beha.2016.10.009 DO - 10.1016/j.beha.2016.10.009 ID - Litzow2016 ER - TY - JOUR AU - Yoon, J. H. AU - Min, G. J. AU - Park, S. S. AU - Jeon, Y. W. AU - Lee, S. E. AU - Cho, B. S. AU - Eom, K. S. AU - Kim, Y. J. AU - Kim, H. J. AU - Min, C. K. PY - 2019 DA - 2019// TI - Minimal residual disease-based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia JO - Cancer VL - 125 UR - https://doi.org/10.1002/cncr.31874 DO - 10.1002/cncr.31874 ID - Yoon2019 ER - TY - JOUR AU - Pfeifer, H. AU - Cazzaniga, G. AU - Velden, V. H. J. AU - Cayuela, J. M. AU - Schafer, B. AU - Spinelli, O. AU - Akiki, S. AU - Avigad, S. AU - Bendit, I. AU - Borg, K. PY - 2019 DA - 2019// TI - Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 JO - Leukemia VL - 33 UR - https://doi.org/10.1038/s41375-019-0413-0 DO - 10.1038/s41375-019-0413-0 ID - Pfeifer2019 ER -